
- Drug Topics September 2019
- Volume 163
- Issue 9
MS Drugs in the Pipeline
Current phase 3 studies investigative novel, preventative approaches.
Multiple sclerosis (MS) is a chronic inflammatory condition that affects the central nervous system (CNS), and it can result in significant disability and death.
Healthcare executives are concerned about the cost, quality, and outcomes of MS drugs, making it a top priority for patient care and expenditures. According to a study published in
Trending:
Legislation that makes MS medications more affordable is needed to alleviate patient costs. Healthcare professionals can play an important role through an interdisciplinary approach to managing patients with MS and identifying financial options such as patient assistance programs to alleviate costs.
Phase 3 MS drugs in the pipeline
Interim efficacy and safety results from the
Banner Life Sciences has received
Read More:
Ozanimod is an oral sphingosine 1-phosphate (S1P) receptor modulator. “With a mechanism of action similar to the recently approved Mayzent (siponimod) and an optimal pharmacokinetic profile, ozanimod hopes to demonstrate an improved safety profile to Gilenya (fingolimod),” says Lopata. Ozanimod has only been studied in relapsing forms of MS; however, Mayzent is FDA approved for both relapsing and secondary progressive populations.
“With the success of Ocrevus (ocrelizumab) for MS, additional CD20-directed monoclonal antibodies are likely to follow,” says Lopata.
Another candidate on the horizon is ublituximab (TG-1101), which is being studied by the biopharmaceutical company
Articles in this issue
about 6 years ago
Biosimilars: Some Call for ‘Cautious Optimism’about 6 years ago
Biosimilars Need Access and Cost Examinationsabout 6 years ago
The Latest Autoimmune Disease Treatment Advancesabout 6 years ago
Unique Offerings Increasing Revenueabout 6 years ago
The Growing Problem of Pharmacy Desertsabout 6 years ago
What is a Pharmacy Desert?about 6 years ago
Patient Services are Crucial to the Economics of Pharmacyabout 6 years ago
New Video Marketing Toolsabout 6 years ago
Antimicrobial Stewardship: Protecting Global HealthNewsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.